These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of 3-methoxycyproheptadine in a canine model of coronary thrombosis.
    Author: Bush LR, Remy DC.
    Journal: J Pharmacol Exp Ther; 1988 Nov; 247(2):796-802. PubMed ID: 3183974.
    Abstract:
    The enantiomers of 3-methoxycyproheptadine (3-MeO-Cyp) were evaluated for their ability to abolish cyclic flow reductions (CFRs) in stenosed and partially de-endothelialized coronary arteries of open chest dogs. These enantiomers demonstrate differential serotonin antagonism with the levorotatory (-) enantiomer showing a selective antiserotonin profile. (+)- and (-)-3-MeO-Cyp each were evaluated in 5 dogs, at doses ranging from 0.01 to 0.5 mg/kg i.v. 1 hr after establishing CFRs, which were quantified in terms of frequency (CFR/hour) and severity (average nadir of coronary blood flow). The frequency or severity of CFRs was not affected consistently by 10 or 25 micrograms/kg of (-)-3-MeO-Cyp; however, 50 micrograms/kg practically abolished CFRs. (+)-3-MeO-Cyp was significantly less potent; complete abolition of CFRs required 0.5 mg/kg of this enantiomer in three dogs, and partial abolition occurred in the other two. These differences between (+)- and (-)-3-MeO-Cyp correlated well with a 12-fold difference in potency for inhibition of canine platelet aggregation stimulated by serotonin and ADP. The IC50's of (-)- and (+)-3-MeO-Cyp vs. ADP plus serotonin-induced aggregation of canine platelet-rich plasma were 1.03 +/- 0.39 (mean +/- S.E.) and 12.92 +/- 4.28 microM, respectively. Thus, (-)-3-MeO-Cyp, a 5-HT2 antagonist devoid of anticholinergic activity and less antihistamine activity than either its enantiomer or parent drug, cyproheptadine, exerts dose-dependent antithrombotic effects in this canine model, providing further evidence that serotonin plays an important role in platelet aggregation and thrombosis.
    [Abstract] [Full Text] [Related] [New Search]